Few of the T1D susceptibility genes (INS and PTPN22 genes) have so far been associated with residual β-cell function and glycaemic control during the first year after diagnosis in newly diagnosed children with T1D [9], [10]. This evidence concerns the gene PTPN22 and type 1 diabetes mellitus.